Phantom Neuro, a neurotechnology company developing minimally invasive neural interfaces for intuitive prosthetic control, announced the opening of its patient registry. The initiative is designed to connect people with upper-limb amputations to upcoming clinical studies and research opportunities.
Consumers, clinicians, and rehabilitation specialists can sign up for updates on future Phantom Neuro trials and early-access programs. By gathering the information, the company aims to better understand patient needs, accelerate study readiness, and ensure diverse representation in its ongoing research.
“Innovation in neurotechnology must start and end with the patient,” said Connor Glass, MD, CEO and founder of Phantom Neuro. “This registry allows us to engage directly with the amputee community, building relationships, understanding real-world challenges, and preparing for future studies that reflect the diversity and priorities of those we serve.”
